Further investigation of the response of human uroepithelium to low doses of cobalt-60 gamma radiation.

Explant cultures of normal human uroepithelium were established, exposed to a range of 60Co gamma-ray doses from 0.1-5 Gy and grown for 14 days. Expression of Myc, p53 and Bc12 proteins in the epithelial cells which grew from irradiated explants was measured in situ using immunocytochemistry. The results show that overexpression of Bc12 with low Myc expression correlated with resistance to radiation as shown by the extent of growth detected on day 14. Strong staining for Myc coupled with low or absent Bc12 expression generally correlated with radiosensitivity, although the level of p53 of the culture was critical in these cases. None of the proteins on their own correlated with radiation response. What appeared to be critical was the balance of cells expressing Bc12 and Myc proteins. Building on the results presented in a previous paper which showed a division of cultures from patients into those showing monotonic and nonmonotonic responses, this study presents results for explant cultures from a greater number of patients and attempts to characterize the profile of expression of the above proteins in the uroepithelium of these patients. It shows that high Bc12/Myc ratios were found in cultures which showed a non-monotonic and resistant dose response. Where Myc was the dominant protein in the culture postirradiation, a radiosensitive and monotonic response tended to occur. Since the proteins are being detected in the distant progeny of irradiated cells, it is likely that changes induced by radiation in the cell population are stable. The measurement of these two proteins can be made in cultured biopsy material and may therefore have predictive value in radiotherapy and radiation protection. Both normal and tumor biopsies from bladder mucosa showed similar correlations between Bc12/Myc ratios and growth postirradiation.

[1]  M. Durante,et al.  Radiation-induced chromosomal instability in human mammary epithelial cells. , 1996, Advances in space research : the official journal of the Committee on Space Research.

[2]  C. Mothersill,et al.  Primary explants of human uroepithelium show an unusual response to low-dose irradiation with cobalt-60 gamma rays. , 1995, Radiation research.

[3]  H. Steller Mechanisms and genes of cellular suicide , 1995, Science.

[4]  D. Goodhead,et al.  Radiation-induced genomic instability: delayed cytogenetic aberrations and apoptosis in primary human bone marrow cells. , 1995, International journal of radiation biology.

[5]  H. Joensuu,et al.  Bcl-2 protein expression and long-term survival in breast cancer. , 1994, The American journal of pathology.

[6]  A. D'Amico,et al.  Apoptosis and a re-investigation of the biologic basis for cancer therapy. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  B. Stewart Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. , 1994, Journal of the National Cancer Institute.

[8]  C. Mothersill,et al.  Induction of stable p53 oncoprotein and of c-myc overexpression in cultured normal human uroepithelium by radiation and N-nitrosodiethanolamine. , 1994, Radiation research.

[9]  C. Mothersill,et al.  High levels of stable p53 protein and the expression of c-myc in cultured human epithelial tissue after cobalt-60 irradiation. , 1994, Radiation research.

[10]  J. Day,et al.  Delayed chromosomal instability induced by DNA damage , 1993, Molecular and cellular biology.

[11]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[12]  K. Kohn,et al.  Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. , 1993, Cancer research.

[13]  Y. Pommier,et al.  bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. , 1993, Cancer research.

[14]  A. Harris,et al.  bcl-2 protein in non-small-cell lung carcinoma. , 1993, The New England journal of medicine.

[15]  S. Korsmeyer,et al.  Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.

[16]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[17]  D. Brachman,et al.  p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. , 1993, Cancer research.

[18]  D. Lane A death in the life of p53 , 1993, Nature.

[19]  N. Hay,et al.  Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 , 1993, Molecular and cellular biology.

[20]  C. Mothersill,et al.  Recovery of the radiation survival-curve shoulder in CHO-KI, XRS-5 and revertant XRS-5 populations. , 1993, Mutation research.

[21]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[22]  D. Green,et al.  Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.

[23]  S. Korsmeyer Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.

[24]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[25]  C. Mothersill,et al.  All colonies of CHO-K1 cells surviving γ-irradiation contain non-viable cells , 1992 .

[26]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[27]  D. T. Goodhead,et al.  Transmission of chromosomal instability after plutonium α-particle irradiation , 1992, Nature.

[28]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[29]  C. Mothersill,et al.  Induction of c-myc oncoprotein and of cellular proliferation by radiation in normal human urothelial cultures. , 1991, Anticancer research.

[30]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[31]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[32]  S. Korsmeyer,et al.  Alternative promoters and exons, somatic mutation and deregulation of the Bcl‐2‐Ig fusion gene in lymphoma. , 1988, The EMBO journal.

[33]  C. Mothersill,et al.  High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[34]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .